Muconic Acid Production via Feedback-Resistant Enzyme Mutants
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing muconic acid from renewable resources are hindered by high costs due to the need for expensive medium components and chemical inducers, and yield levels are insufficient for industrial production.
Innovation Solution
Genetically engineered microorganisms are developed to produce cis, cis-muconic acid from non-aromatic carbon sources like sugars, with modifications to reduce feedback inhibition and enhance enzyme activity in the aromatic amino acid pathway, including the use of feedback-resistant enzymes and overexpression of key genes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If genetically engineered microorganisms are used to produce muconic acid from renewable resources, then environmental friendliness is improved, but production yield is insufficient for industrial application
Solution Approach 1:
The patent applies parameter changes by modifying enzyme properties through site-directed mutagenesis. Specifically, AroE enzyme mutants are created with altered substrate affinity and catalytic activity parameters, enabling efficient conversion of DHS to shikimate while preventing muconic acid degradation. The aroG gene is also mutated to create feedback-resistant DAHP synthase variants that maintain high pathway flux. These parameter modifications resolve the contradiction by achieving both environmental sustainability and industrial-scale productivity.
Solution Approach 2:
The patent employs copying by introducing multiple copies of the aroG gene into the E. coli genome. This gene amplification strategy increases the total cellular capacity for DAHP synthase activity, thereby enhancing the overall flux through the aromatic amino acid pathway toward muconic acid production. The copied genes are integrated at specific genomic loci to ensure stable inheritance and consistent expression, directly addressing the yield limitation while maintaining the environmentally friendly fermentation approach.
2Productivity
If expensive medium components and chemical inducers are used in muconic acid production, then pathway expression is enhanced, but production cost increases
Solution Approach 1:
The patent implements self-service by engineering the microorganism to autonomously regulate and sustain high-level expression of the muconic acid pathway without external chemical inducers. The feedback-resistant aroG mutant and optimized gene architecture enable the system to automatically maintain pathway flux through endogenous metabolic signals. This eliminates the need for expensive inducing agents while preserving high production efficiency, directly resolving the cost-efficiency contradiction.
Solution Approach 2:
The patent extracts and removes the dependency on expensive medium components and chemical inducers from the production system. By engineering feedback-resistant enzymes and optimizing the genetic architecture, the system achieves high muconic acid yields using only inexpensive renewable carbon sources and standard minimal media. This extraction of unnecessary cost elements maintains productivity while dramatically reducing production costs.
3Stability of the object's composition
If feedback inhibition is present in the aromatic amino acid pathway, then metabolic control is maintained, but muconic acid production is limited
Solution Approach 1:
The patent applies inversion by creating feedback-resistant variants of key pathway enzymes, particularly the aroG gene encoding DAHP synthase. Instead of relying on natural feedback inhibition to control metabolism, the mutated enzymes are designed to be insensitive to end-product inhibition, thereby inverting the regulatory logic. This allows metabolic flux to be directed toward muconic acid production without being restrained by feedback control mechanisms, resolving the contradiction between metabolic stability and production yield.
Solution Approach 2:
The patent modifies the kinetic parameters of pathway enzymes through site-directed mutagenesis to alter their regulatory properties. The aroG gene is mutated to produce DAHP synthase with changed sensitivity to feedback inhibition, while aroE is mutated to optimize catalytic efficiency. These parameter changes enable the pathway to maintain controlled metabolism through alternative mechanisms while achieving high muconic acid yields不受反馈抑制的限制.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach increases the yield and reduces production costs by utilizing cheaper carbon sources and eliminating the need for chemical inducers, making the process more economically viable for industrial-scale muconic acid production.
Implementation Method 1
produce cis, cis-muconic acid from non-aromatic carbon sources, such as sugars and carbohydrates including, but not limited to glucose, sucrose, glycerol and cellulosic hydrolysate
Data Source
AI summary
The subject of this invention is improvements in the yield and titer of biological production of muconic acid by fermentation. Increased activity of one or more enzymes involved in the muconic acid pathway leads to increased production of muconic acid.